|
1
|
Rasmussen F: Metastatic renal cell cancer.
Cancer Imaging. 13:374–380. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cheville JC, Lohse CM, Zincke H, Weaver AL
and Blute ML: Comparisons of outcome and prognostic features among
histologic subtypes of renal cell carcinoma. Am J Surg Pathol.
27:612–624. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen Z, Zhang J, Zhang Z, Feng Z, Wei J,
Lu J, Fang Y, Liang Y, Cen J, Pan Y, et al: The putative tumor
suppressor microRNA-30a-5p modulates clear cell renal cell
carcinoma aggressiveness through repression of ZEB2. Cell Death
Dis. 8:e28592017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chow WH and Devesa SS: Contemporary
epidemiology of renal cell cancer. Cancer J. 14:288–301. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hadoux J, Vignot S and De La Motte Rouge
T: Renal cell carcinoma: Focus on safety and efficacy of
temsirolimus. Clin Med Insights Oncol. 4:143–154. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu TY, Li J, Wen XH, Zhang H and Gui Q:
The efficacy of open nephron-sparing surgery in the treatment of
complex renal cell carcinoma. Eur Rev Med Pharmacol Sci.
20:3959–3964. 2016.PubMed/NCBI
|
|
8
|
Ljungberg B, Bensalah K, Canfield S,
Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L,
Merseburger AS, et al: EAU guidelines on renal cell carcinoma: 2014
update. Eur Urol. 67:913–924. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lui PY, Jin DY and Stevenson NJ: MicroRNA:
Master controllers of intracellular signaling pathways. Cell Mol
Life Sci. 72:3531–3542. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jonas S and Izaurralde E: Towards a
molecular understanding of microRNA-mediated gene silencing. Nat
Rev Genet. 16:421–433. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Giannakakis A, Coukos G, Hatzigeorgiou A,
Sandaltzopoulos R and Zhang L: miRNA genetic alterations in human
cancers. Expert Opin Biol Ther. 7:1375–1386. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang R, Ma Y, Yu D, Zhao J and Ma P:
miR-377 functions as a tumor suppressor in human clear cell renal
cell carcinoma by targeting ETS1. Biomed Pharmacother. 70:64–71.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lei Z, Ma X, Li H, Zhang Y, Gao Y, Fan Y,
Li X, Chen L, Xie Y, Chen J, et al: Up-regulation of miR-181a in
clear cell renal cell carcinoma is associated with lower KLF6
expression, enhanced cell proliferation, accelerated cell cycle
transition, and diminished apoptosis. Urol Oncol. Oct 20–2017.(Epub
ahead of print). PubMed/NCBI
|
|
15
|
Cao J, Liu J, Xu R, Zhu X, Liu L and Zhao
X: MicroRNA-21 stimulates epithelial-to-mesenchymal transition and
tumorigenesis in clear cell renal cells. Mol Med Rep. 13:75–82.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nakata W, Uemura M, Sato M, Fujita K,
Jingushi K, Ueda Y, Kitae K, Tsujikawa K and Nonomura N: Expression
of miR-27a-3p is an independent predictive factor for recurrence in
clear cell renal cell carcinoma. Oncotarget. 6:21645–21654. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiao H, Zeng J, Li H, Chen K, Yu G, Hu J,
Tang K, Zhou H, Huang Q, Li A, Li Y, et al: MiR-1 downregulation
correlates with poor survival in clear cell renal cell carcinoma
where it interferes with cell cycle regulation and metastasis.
Oncotarget. 6:13201–13215. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y, Sui Y, Zhu Q and Sui X:
Hsa-miR-599 suppresses the migration and invasion by targeting BRD4
in breast cancer. Oncol Lett. 14:3455–3462. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tian J, Hu X, Gao W, Zhang J, Chen M,
Zhang X, Ma J and Yuan H: Identification a novel tumor-suppressive
hsa-miR-599 regulates cells proliferation, migration and invasion
by targeting oncogenic MYC in hepatocellular carcinoma. Am J Transl
Res. 8:2575–2584. 2016.PubMed/NCBI
|
|
20
|
Zhang T, Ma G, Zhang Y, Huo H and Zhao Y:
miR-599 inhibits proliferation and invasion of glioma by targeting
periostin. Biotechnol Lett. 39:1325–1333. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang D, Zhu C, Zhang Y, Zheng Y, Ma F, Su
L and Shao G: MicroRNA-30e-3p inhibits cell invasion and migration
in clear cell renal cell carcinoma by targeting Snail1. Oncol Lett.
13:2053–2058. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fan W, Huang J, Xiao H and Liang Z:
MicroRNA-22 is downregulated in clear cell renal cell carcinoma,
and inhibits cell growth, migration and invasion by targeting PTEN.
Mol Med Rep. 13:4800–4806. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma X, Shen D, Li H, Zhang Y, Lv X, Huang
Q, Gao Y, Li X, Gu L, Xiu S, et al: MicroRNA-185 inhibits cell
proliferation and induces cell apoptosis by targeting VEGFA
directly in von Hippel-Lindau-inactivated clear cell renal cell
carcinoma. Urol Oncol. 33:169.e1–11. 2015. View Article : Google Scholar
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu Y, Fu QZ, Pu L, Meng QG, Liu XF, Dong
SF, Yang JX and Lv GY: HMGA2 expression in renal carcinoma and its
clinical significance. J Med Biochem. 34:338–343. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Na N, Si T, Huang Z, Miao B, Hong L, Li H
and Qiu J and Qiu J: High expression of HMGA2 predicts poor
survival in patients with clear cell renal cell carcinoma. Onco
Targets Ther. 9:7199–7205. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu Y, Fu QZ, Pu L, Song LL, Wang YY, Liu
J, Wang ZL and Wang ZM: Effect of RNA interference of the
expression of HMGA2 on the proliferation and invasion ability of
ACHN renal cell carcinoma cells. Mol Med Rep. 16:5107–5112. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kou B, Liu W, Tang X and Kou Q: HMGA2
facilitates epithelial-mesenchymal transition in renal cell
carcinoma by regulating the TGF-β/Smad2 signaling pathway. Oncol
Rep. 39:101–108. 2018.PubMed/NCBI
|
|
29
|
Liu LJ, Yu JJ and Xu XL: MicroRNA-93
inhibits apoptosis and promotes proliferation, invasion and
migration of renal cell carcinoma ACHN cells via the TGF-β/Smad
signaling pathway by targeting RUNX3. Am J Transl Res. 9:3499–3513.
2017.PubMed/NCBI
|
|
30
|
He YH, Chen C and Shi Z: The biological
roles and clinical implications of microRNAs in clear cell renal
cell carcinoma. J Cell Physiol. Dec 7–2017.(Epub ahead of
print).
|
|
31
|
Xiao W, Lou N, Ruan H, Bao L, Xiong Z,
Yuan C, Tong J, Xu G, Zhou Y, Qu Y, et al: Mir-144-3p promotes cell
proliferation, metastasis, sunitinib resistance in clear cell renal
cell carcinoma by downregulating ARID1A. Cell Physiol Biochem.
43:2420–2433. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang X, Jin Y, Zhang H, Huang X, Zhang Y
and Zhu J: MicroRNA-599 inhibits metastasis and
epithelial-mesenchymal transition via targeting EIF5A2 in gastric
cancer. Biomed Pharmacother. 97:473–480. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tian W, Wang G, Liu Y, Huang Z, Zhang C,
Ning K, Yu C, Shen Y, Wang M, Li Y, et al: The miR-599 promotes
non-small cell lung cancer cell invasion via SATB2. Biochem Biophys
Res Commun. 485:35–40. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun M, Song CX, Huang H, Frankenberger CA,
Sankarasharma D, Gomes S, Chen P, Chen J, Chada KK, He C and Rosner
MR: HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer
growth and metastasis. Proc Natl Acad Sci USA. 110:pp. 9920–9925.
2013; View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Belge G, Meyer A, Klemke M, Burchardt K,
Stern C, Wosniok W, Loeschke S and Bullerdiek J: Upregulation of
HMGA2 in thyroid carcinomas: A novel molecular marker to
distinguish between benign and malignant follicular neoplasias.
Genes Chromosomes Cancer. 47:56–63. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Esmailzadeh S, Mansoori B, Mohammadi A,
Shanehbandi D and Baradaran B: siRNA-mediated silencing of HMGA2
induces apoptosis and cell cycle arrest in human colorectal
carcinoma. J Gastrointest Cancer. 48:156–163. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kaur H, Ali SZ, Huey L, Hütt-Cabezas M,
Taylor I, Mao XG, Weingart M, Chu Q, Rodriguez FJ, Eberhart CG and
Raabe EH: The transcriptional modulator HMGA2 promotes stemness and
tumorigenicity in glioblastoma. Cancer Lett. 377:55–64. 2016.
View Article : Google Scholar :
|
